Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide.
Yohei KumanoYoriko HasegawaTakashi KawaharaMasato YasuiYasuhide MiyoshiNobuaki MatsubaraHiroji UemuraPublished in: BioMed research international (2019)
The NLR might be a useful biomarker for predicting the prognosis of mCRPC patients who are treated with ENZ.